Top Story

Researcher looks at relationship between atopic dermatitis, obesity and cardiovascular disease

March 30, 2015

SAN FRANCISCO — In this video, Jonathan I. Silverberg, MD, PhD, MPH, discusses studies examining cardiovascular risk in atopic dermatitis that he reviewed at the American Academy of Dermatology meeting.

 “Both children and adults with atopic dermatitis are at higher risk for obesity and cardiovascular disease” Silverberg, assistant professor of dermatology, medical social sciences and preventive medicine at Northwestern University Feinberg School of Medicine,  told Healio.com/Dermatology. “It is a comorbidity that we need to be cognizant of and address in clinical practice.”

In the Journals

Higher TSH levels linked to unfavorable lipid levels in children, adolescents

March 30, 2015
In children and adolescents, higher levels of thyroid stimulating hormone are associated with less favorable lipid profiles, according to recent findings. Natalie B. V
In the Journals

Canadian pediatric obesity guidelines recommend lifestyle changes, discourage drugs or surgery

March 30, 2015
In its first update in 20 years to obesity guidelines specifically for children, the Canadian Task Force on Preventive Health Care advises routine monitoring of…
Michele Jonsson Funk In the Journals

Risk for adverse neonatal outcomes linked to glyburide

March 30, 2015
Gestational diabetes has been increasingly treated with glyburide; however, the medication is associated with a higher risk for newborns to be admitted to the neonatal…

Experts discuss whether shift in Medicare will reduce costs, improve quality of care

March 30, 2015
In response to concerns over Medicare’s current fee-for-service payment system, the Obama administration announced in January that by 2018 Medicare instead will…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Meeting News Coverage Video
thumbnail for video 4131516814001

'The time has come' for individualized treatment for obese, overweight patients

March 24, 2015
SAN FRANCISCO — Michael Camilleri, MD, AGAF, from the Mayo Clinic in Rochester, Minn., discusses his presentation…
More »
CME
Assessing Cornerstones for Successful Weight Loss

Assessing Cornerstones for Successful Weight Loss: Building a Foundation that Really Works

This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc.

Obesity has increased dramatically in the past 2 decades and is now considered a health care epidemic in the United…
More »
Current Issues
View the Current Issues
morganatic-roan
morganatic-roan